Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.

@article{Parra2016ClinicalAH,
  title={Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.},
  author={Camila Anna Hofbauer Parra and Mariana Figueroa Careta and Neusa Yuriko Sakai Valente and Nuno Eduardo Guimaraes de Sanches Os{\'o}rio and L Torezan},
  journal={Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]},
  year={2016},
  volume={42 4},
  pages={507-12}
}
BACKGROUND Melasma is a frequent and difficult to treat skin disorder. Results of laser therapy are inconsistent. OBJECTIVE To determine the safety and efficacy of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (QS Nd:YAG) laser for melasma treatment and assess recurrence rates and histopathologic findings before and after treatment. METHODS Twenty patients were treated with 10 weekly sessions of low-fluence 1064-nm QS Nd:YAG laser at 1-week intervals. The modified Melasma… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Similar Papers

Loading similar papers…